L. G. . GAMA and C. J. . CABO, “Safety profile of Trastuzumab deruxtecan in patients with advanced HER2+ breast cancer: an active pharmacovigilance study”, J Hosp Pharm Health Serv, vol. 16, no. 2, p. e1259, Jun. 2025.